Nick Pizzie - 21 Apr 2026 Form 4 Insider Report for Axsome Therapeutics, Inc. (AXSM)

Reporting relationship: Chief Financial Officer
Issuer ticker: AXSM
Reported as of: 21 Apr 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 23 Apr 2026, 21:00:44 UTC
Prior SEC filing: 27 Feb 2026
Next SEC filing: 09 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ Nick Pizzie

Key filing fact

Nick Pizzie filed Form 4 for Axsome Therapeutics, Inc. (AXSM) on 23 Apr 2026.

Key facts

This page summarizes Nick Pizzie's Form 4 filing for Axsome Therapeutics, Inc. (AXSM).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 23 Apr 2026, 21:00.

Change

Previous filing in this sequence was filed on 27 Feb 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001742143 Primary reporting owner

Pizzie Nick

Relationship: Chief Financial Officer
Address: C/O AXSOME THERAPEUTICS, INC., ONE WORLD TRADE CENTER, 29TH FLOOR, NEW YORK
Signature: /s/ Nick Pizzie
Signature date: 23 Apr 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

AXSM transaction Derivative

Performance Stock Units

Award

Transaction value
Shares: +8,188
Change %
Price: $0.000000^*
Shares after: 8,188
Date: 21 Apr 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 8,188
Exercise price
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Each performance stock unit ("PSU") represents a contingent right to receive one share of the Issuer's common stock.

Footnote F2

Each PSU will vest upon achievement of certain sales and commercial launch milestones, subject to the reporting person's continued service as of each vesting date.